Literature DB >> 3104949

A comparative assay of nefopam, morphine and d-amphetamine.

D R Jasinski, K L Preston.   

Abstract

Nefopam is a non-opioid analgesic reported to have some stimulant properties. The subjective, behavioral and physiological effects of nefopam, morphine and d-amphetamine were compared in seven non-dependent substance abusers to assess the abuse potential of nefopam. Morphine and d-amphetamine had significant effects on a number of measures generally consistent with the effects of drugs of the opioid and psychomotor stimulant drug classes. Subjects correctly discriminated between morphine and d-amphetamine. Nefopam was most frequently identified by subjects as being amphetamine-like, though several measures indicated that nefopam produced some sedation. Little or no "liking" of the effects of nefopam was reported by subjects. Overall, nefopam was one fifth as potent as morphine and one quarter as potent as d-amphetamine in producing subjective and physiological effects. The results indicate that nefopam is neither entirely morphine-like nor d-amphetamine-like. In our opinion, nefopam has a lesser potential to be abused than morphine or d-amphetamine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104949     DOI: 10.1007/bf00518176

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Assessing the subjective effects of stimulants in casual users. A methodology and preliminary results.

Authors:  J O Cole; H G Pope; R LaBrie; M Ionescu-Pioggia
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

2.  Benzoxazocines: a new chemical class of centrally acting skeletal muscle relaxants.

Authors:  M W Klohs; M D Draper; F J Petracek; K H Ginzel; O N Ré
Journal:  Arzneimittelforschung       Date:  1972-01

3.  In vitro biochemical effects of nefopam hydrochloride, a new analgesic agent.

Authors:  N J Tresnak-Rustad; M E Wood
Journal:  Biochem Pharmacol       Date:  1981-10       Impact factor: 5.858

4.  Nefopam and morphine in man.

Authors:  A Sunshine; E Laska
Journal:  Clin Pharmacol Ther       Date:  1975-11       Impact factor: 6.875

5.  Controlled clinical trial of oral and parenteral nefopam hydrochloride. A novel and potent analgesic drug.

Authors:  M M Gassel; E Diamantopoulos; V Petropoulos; A C Hughes; M L Ballesteros; O N Ré
Journal:  J Clin Pharmacol       Date:  1976-01       Impact factor: 3.126

6.  Respiratory and metabolic effects of oral nefopam in human volunteers.

Authors:  A M Bhatt; B J Pleuvry; S E Maddison
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

7.  Involvement of biogenic amines with the mechanisms of novel analgesics.

Authors:  P F Vonvoigtlander; R A Lewis; G L Neff; H J Triezenberg
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1983       Impact factor: 5.067

8.  Nefopam and propoxyphene in episiotomy pain.

Authors:  S S Bloomfield; T P Barden; J Mitchell
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

9.  Spinal and Supraspinal sites for morphine and nefopam analgesia in the mouse.

Authors:  M F Piercey; L A Schroeder
Journal:  Eur J Pharmacol       Date:  1981-09-11       Impact factor: 4.432

10.  Long-term safety of Nefopam hydrochloride (Acupan), a new analgesic formulation.

Authors:  A L Klotz
Journal:  Curr Ther Res Clin Exp       Date:  1974-06
View more
  2 in total

1.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans.

Authors:  F V Abbott; P Etienne; K B Franklin; M J Morgan; M J Sewitch; S N Young
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.